Adult studies suggest that genetics, pathophysiology, and clinical outcomes may be more strongly associated with antibody status than with the clinical syndromes [20]; although the populations defined by PR3 or MPO antibodies overlap with GPA and MPA, respectively, they are not the same. Here, PRTN3 is linked to microscopic polyangiitis.